Fate Therapeutics (FATE) Tops Q3 EPS by 2c

November 7, 2016 5:14 PM EST
Get Alerts FATE Hot Sheet
Trade FATE Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Fate Therapeutics (NASDAQ: FATE) reported Q3 EPS of ($0.27), $0.02 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Fate Therapeutics (FATE) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment